BioRestorative Therapies IncBRTX
Price$2.27Intrinsic value$2.9630% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $2.96median of 2 methodsbased on filings through 31 Mar 2026
Market Price $2.27Price as of 1 Oct 2026
Margin of Safety +30.5%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 8.6%
Volatility vs market (adjusted beta)0.82

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetBioRestorative Therapies IncBRTXHealth Care
Valuation
P/E—
P/S10.4×
P/B16.3×
EV / Revenue1.7×
EV / EBITDA-0.4×
Profitability
Gross margin93.4%
Operating margin-4,350.1%
Net margin-3,089.6%
FCF margin-3,356.2%
Returns
ROE-365.4%
ROA-238.3%
ROIC—
Growth
Revenue growth (YoY)-10.8%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.00×
Current ratio2.35×
Altman Z-Score-60.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.